Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users
NCT07591740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 725
Last updated 2026-05-18
Summary
A multi-site observation study that was conducted in the United States at 3 CLIA Waived sites with Untrained Users testing on Xpert Hemorrhagic fever tests on Edge X instruments
Conditions
- Hemorrhagic Fever
Interventions
- DIAGNOSTIC_TEST
-
Xpert Hemorrhagic Fever test
Detection and identification of RNA from multiple viruses in CWB and VWB from individuals with signs and symptoms of the suspected infections and/or individuals who are at risk for exposure or may have been exposed to these viruses.
Sponsors & Collaborators
-
Cepheid
lead INDUSTRY
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-21
- Primary Completion
- 2025-03-14
- Completion
- 2026-03-13
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Determining the Fingerprint of Endotoxin Tolerance
NCT06801873 ·Status: COMPLETED ·Phase: NA
-
Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
NCT01878383 ·Status: COMPLETED
-
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NCT05618431 ·Status: RECRUITING ·Phase: NA
-
Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
NCT04955717 ·Status: COMPLETED ·Phase: NA
-
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
NCT04718220 ·Status: COMPLETED ·Phase: NA
-
COVID-19 and Obstetric Transmission
NCT04418557 ·Status: COMPLETED
-
Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital
NCT04385914 ·Status: UNKNOWN
-
Covid-19 Infection in Pregnancy
NCT04869202 ·Status: COMPLETED
-
Evaluation of the Levels of Calcitonin Gene-related Peptide and Substance P
NCT06510751 ·Status: RECRUITING
-
Clinical Utility of Rapid CT/NG Testing in the ED
NCT02200224 ·Status: COMPLETED ·Phase: NA
-
Proteinuria During Acute Pyelonephritis In Pregnancy
NCT02536638 ·Status: COMPLETED
-
mulTiplex Immunoassay qualiTy assuRance Panel
NCT07562061 ·Status: RECRUITING
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED
-
Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with Pyelonephritis
NCT06527560 ·Status: RECRUITING ·Phase: PHASE4
-
Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains
NCT02718157 ·Status: COMPLETED ·Phase: NA
-
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
NCT06815536 ·Status: RECRUITING
-
The Mycophenolate Pregnancy Registry
NCT01733082 ·Status: RECRUITING
-
Maternal- Fetal Infection
NCT03371056 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
NCT03842189 ·Status: COMPLETED ·Phase: PHASE2
-
Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor
NCT02511444 ·Status: COMPLETED ·Phase: NA
-
Interest of the Presepsin Assay as a Biomarker of Bacterial Infection, in the Management of Newborns and Infants Under 3 Months of Age Admitted for Fever in Pediatric Emergency Service (Presepsin)
NCT04076345 ·Status: TERMINATED
-
Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)
NCT05832502 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syphilis Advanced Test.
NCT06584214 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Radiofrequency Electromagnetic Fields and Pregnancy : Exposure Specificities and Evolution
NCT06721481 ·Status: NOT_YET_RECRUITING
-
Rapid Detection of Group B Strep- 35-37 Week Study
NCT00331019 ·Status: WITHDRAWN